Physician profile
Roy A Kline
NPI 1841254125
$821,962.20
in general payments reported to CMS, 2019-2025
16 companies · $51K in 2025
The $51K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124K · 2020: $38K · 2021: $127K · 2022: $178K · 2023: $160K · 2024: $144K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $236K · Travel and Lodging: $87K · Consulting Fee: $19K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $236,000.00 |
| Travel and Lodging | $87,183.29 |
| Consulting Fee | $19,350.00 |
| Food and Beverage | $12,859.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $532,314.81 | 2022-2025 | Infuse, Infuse Multifocal, Ultra Multifocal Toric |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $288,465.89 | 2019-2021 | |
| Allergan, INC. | $221.52 | 2019-2022 | |
| Amgen INC. | $190.38 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $174.95 | 2020-2025 | Tryptyr |
| Astellas Pharma US INC | $122.88 | 2023 | Izervay |
| Glaukos Corporation | $122.77 | 2025 | Photrexa Viscous and Photrexa |
| Spark Therapeutics, INC. | $91.82 | 2019 | |
| Sight Sciences, INC. | $46.95 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $46.84 | 2021 | |
| Sun Pharmaceutical Industries INC. | $46.08 | 2019 | |
| Coopervision INC. | $40.40 | 2019 | |
| Abbvie INC. | $27.15 | 2022-2024 | |
| Carl Zeiss Meditec, INC. | $18.47 | 2019 | |
| Biotissue Holdings INC. | $16.36 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $14.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Kline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.